Mixed Topics
From the Journals
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.
Latest News
Today’s top news highlights: Remdesivir data dive, FDA approves contraceptive gel
FDA approves the first contraceptive gel and researchers published full results from a remdesivir trial.
Commentary
COVID-19 and Mental Health Awareness Month
As a community, we must be prepared to meet the escalating needs of our population, said Dr. Eva Ritvo.
Conference Coverage
Many hydroxychloroquine COVID-19 prophylaxis trials lack ECG screening
From the Journals
Evidence builds linking anticoagulation to COVID-19 survival
“Any family of mine who will have this disease absolutely will be on antithrombotic therapy and, actually, so are all of the patients at Mount...
From the Journals
New angiotensin studies in COVID-19 give more reassurance
A deluge of new data does not suggest harm with ACE inhibitors and angiotensin blockers in COVID-19 rates or outcomes.
From the Journals
Multisociety roadmap eyes restarting elective cardiac cases
From the Journals
Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients
From the Journals
Out-of-hospital cardiac arrests soar during COVID-19 in Italy
Conference Coverage
COVID-19: A ‘marathon, not a sprint’ for psychiatry
Providing emotional support will help individuals engage with instrumental supports, said Dr. Joshua Morganstein.
Feature
New study of diabetes drug for COVID-19 raises eyebrows